PT1176960E - Combinacao sinergica compreendendo roflumilast e um inibidor de pde-3 - Google Patents
Combinacao sinergica compreendendo roflumilast e um inibidor de pde-3Info
- Publication number
- PT1176960E PT1176960E PT00927094T PT00927094T PT1176960E PT 1176960 E PT1176960 E PT 1176960E PT 00927094 T PT00927094 T PT 00927094T PT 00927094 T PT00927094 T PT 00927094T PT 1176960 E PT1176960 E PT 1176960E
- Authority
- PT
- Portugal
- Prior art keywords
- pde
- inhibitor
- combination
- sinergica
- roflumilast
- Prior art date
Links
- 229940123263 Phosphodiesterase 3 inhibitor Drugs 0.000 title 1
- 239000002570 phosphodiesterase III inhibitor Substances 0.000 title 1
- MNDBXUUTURYVHR-UHFFFAOYSA-N roflumilast Chemical compound FC(F)OC1=CC=C(C(=O)NC=2C(=CN=CC=2Cl)Cl)C=C1OCC1CC1 MNDBXUUTURYVHR-UHFFFAOYSA-N 0.000 title 1
- 229960002586 roflumilast Drugs 0.000 title 1
- 239000003112 inhibitor Substances 0.000 abstract 2
- 208000009079 Bronchial Spasm Diseases 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- KXDAEFPNCMNJSK-UHFFFAOYSA-N benzene carboxamide Natural products NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99108808 | 1999-05-04 | ||
| PCT/EP2000/003838 WO2000066123A1 (en) | 1999-05-04 | 2000-04-27 | Synergistic combination comprising roflumilast and a pde-3 inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1176960E true PT1176960E (pt) | 2005-02-28 |
Family
ID=8238107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00927094T PT1176960E (pt) | 1999-05-04 | 2000-04-27 | Combinacao sinergica compreendendo roflumilast e um inibidor de pde-3 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6498173B1 (pt) |
| EP (1) | EP1176960B1 (pt) |
| JP (1) | JP2002543133A (pt) |
| AT (1) | ATE277616T1 (pt) |
| AU (1) | AU4558800A (pt) |
| CA (1) | CA2372850C (pt) |
| DE (1) | DE60014353T2 (pt) |
| ES (1) | ES2228512T3 (pt) |
| PT (1) | PT1176960E (pt) |
| SI (1) | SI1176960T1 (pt) |
| WO (1) | WO2000066123A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001090076A1 (en) * | 2000-05-25 | 2001-11-29 | Merck Frosst Canada & Co. | Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor |
| WO2002051502A1 (en) * | 2000-12-22 | 2002-07-04 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Combined inhibition of phosphodiesterase-4 (pde-4) and phosphodiesterase-3 (pde-3) as a therapy for th1-mediated autoimmune diseases |
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| US6822114B1 (en) | 2002-10-08 | 2004-11-23 | Albemarle Corporation | Process for production of fluoroalkoxy-substituted benzamides and their intermediates |
| KR101179012B1 (ko) | 2003-03-10 | 2012-09-03 | 니코메드 게엠베하 | 로플루미라스트 신규한 제조 방법 |
| EP1861074B1 (en) | 2005-03-16 | 2013-04-24 | Takeda GmbH | Taste masked dosage form containing roflumilast |
| RU2007149249A (ru) * | 2005-06-09 | 2009-07-20 | Сантен Фармасьютикал Ко., Лтд (Jp) | Глазные капли, содержащие рофлумиласт |
| JP2009514969A (ja) | 2005-11-09 | 2009-04-09 | コンビナトアールエックス インコーポレーティッド | 医学的状態を治療するための方法、組成物、およびキット |
| WO2019147824A1 (en) | 2018-01-26 | 2019-08-01 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a pde4 inhibitor |
| WO2020106757A1 (en) | 2018-11-19 | 2020-05-28 | Progenity, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
| CN115666704B (zh) | 2019-12-13 | 2025-09-26 | 比特比德科有限责任公司 | 用于将治疗剂递送至胃肠道的可摄取装置 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8929208D0 (en) * | 1989-12-27 | 1990-02-28 | Almirall Lab | New xanthine derivatives |
| US5712298A (en) * | 1993-07-02 | 1998-01-27 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| EP0961616A4 (en) * | 1996-09-13 | 2000-11-22 | Trustees Of Board Of | NON-HORMONAL CONTRACEPTIVE METHOD |
| US5874437A (en) * | 1996-11-01 | 1999-02-23 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
-
2000
- 2000-04-27 ES ES00927094T patent/ES2228512T3/es not_active Expired - Lifetime
- 2000-04-27 SI SI200030562T patent/SI1176960T1/xx unknown
- 2000-04-27 CA CA2372850A patent/CA2372850C/en not_active Expired - Lifetime
- 2000-04-27 US US09/959,599 patent/US6498173B1/en not_active Expired - Lifetime
- 2000-04-27 WO PCT/EP2000/003838 patent/WO2000066123A1/en not_active Ceased
- 2000-04-27 EP EP00927094A patent/EP1176960B1/en not_active Expired - Lifetime
- 2000-04-27 PT PT00927094T patent/PT1176960E/pt unknown
- 2000-04-27 DE DE60014353T patent/DE60014353T2/de not_active Expired - Lifetime
- 2000-04-27 AU AU45588/00A patent/AU4558800A/en not_active Abandoned
- 2000-04-27 JP JP2000615008A patent/JP2002543133A/ja active Pending
- 2000-04-27 AT AT00927094T patent/ATE277616T1/de active
-
2002
- 2002-11-04 US US10/286,915 patent/US6897229B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6498173B1 (en) | 2002-12-24 |
| EP1176960A1 (en) | 2002-02-06 |
| US20030050329A1 (en) | 2003-03-13 |
| AU4558800A (en) | 2000-11-17 |
| EP1176960B1 (en) | 2004-09-29 |
| DE60014353T2 (de) | 2005-10-13 |
| JP2002543133A (ja) | 2002-12-17 |
| ES2228512T3 (es) | 2005-04-16 |
| ATE277616T1 (de) | 2004-10-15 |
| CA2372850A1 (en) | 2000-11-09 |
| DE60014353D1 (de) | 2004-11-04 |
| CA2372850C (en) | 2011-01-18 |
| US6897229B2 (en) | 2005-05-24 |
| WO2000066123A1 (en) | 2000-11-09 |
| SI1176960T1 (en) | 2005-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1202986T3 (da) | Amin- og amidderivater som ligander for neuropeptid Y-Y5-receptoren, der er nyttige ved behandlingen af obesitet og andre lidelser | |
| PT1176960E (pt) | Combinacao sinergica compreendendo roflumilast e um inibidor de pde-3 | |
| JO2311B1 (en) | Alkyl inhibitors Ariel phosphodiesterase-4 | |
| NO20014479D0 (no) | Fremgangsmåte ved behandling av spiseforstyrrelser | |
| DK0772603T3 (da) | Substituerede pyrimidinforbindelser og deres anvendelse | |
| MXPA03006260A (es) | Derivados de amina sustituidos y metodos de uso. | |
| BR0112292A (pt) | Composto, composição farmacêutica, método para tratar ou prevenir disfunções tromboembólicas e uso de um composto | |
| DK1355889T3 (da) | Substituerede triazoldiaminderivater som kinaseinhibitorer | |
| ID27838A (id) | Inhibitor 1,2,3,4-tetrahidrokinolin tersubstitusi 2-tersubstitusi 4-amino sebagai inhibitor cetp | |
| DK1173484T3 (da) | Behandling af fibrose ved antagonisme mellem IL-13 og IL-13-receptorkæder | |
| DK1076657T3 (da) | Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling | |
| AU2002340010A1 (en) | Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors | |
| AU4064597A (en) | Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof | |
| NO923089D0 (no) | Tetrahydroindazol, tetrahydrocyklopentapyrazol og heksahydrocykloheptapyrazol forbindelser og deres anvendelse som hmg-coa reduktase-hemmere | |
| MXPA03009750A (es) | Compuestos quimicos. | |
| WO2002003978A3 (en) | A COMBINATION OF FBPase INHIBITORS AND ANTIDIABETIC AGENTS USEFUL FOR THE TREATMENT OF DIABETES | |
| SI1173439T1 (en) | Haloalkoxy imidazonaphthyridines | |
| CA2412596A1 (en) | Cyclic gmp-specific phosphodiesterase inhibitors | |
| SG52662A1 (en) | Arylkalkyl-amines and -amides having anticonvulsant and neuroprotective properties | |
| MXPA03004023A (es) | Compuestos quimicos. | |
| MY133169A (en) | Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect | |
| PT1161239E (pt) | 3-ciclopropilmetoxi-4-difluorometoxi-n-(3,5-dicloropirid-4-il)-benzamida para o tratamento da esclerose multipla | |
| CA2423357A1 (en) | Fused heterocyclic derivatives as phosphodiesterase inhibitors | |
| SE0103795D0 (sv) | Compounds and method for the treatment of överactive bladder | |
| SE0103668D0 (sv) | Method for the treatment of overactive blader |